|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 8
Zeitschriftenartikel
Azam, Khalide; Khosa, Celso; Viegas, Sofia; Massango, Isabel; Bhatt, Nilesh; Jani, Ilesh; Heinrich, Norbert; Hoelscher, Michael; Gillespie, Stephen H.; Rachow, Andrea und Sabiiti, Wilber
(2022):
Reduction of blood C-reactive protein concentration complements the resolution of sputum bacillary load in patients on anti-tuberculosis therapy.
In: Frontiers in Immunology, Bd. 13, 1005692
Evans, Denise; Rensburg, Craig van; Govathson, Caroline; Ivanova, Olena; Riess, Friedrich; Siroka, Andrew; Sillah, Abdou K.; Ntinginya, Nyanda Elias; Jani, Ilesh; Sathar, Farzana; Rosen, Sydney; Sanne, Ian; Rachow, Andrea und Lonnroth, Knut
(2021):
Adaptation of WHO's generic tuberculosis patient cost instrument for a longitudinal study in Africa.
In: Global Health Action, Bd. 14, Nr. 1, 1865625
Meggi, Bindiya; Bollinger, Timothy; Zitha, Alcina; Mudenyanga, Chishamiso; Vubil, Adolfo; Mutsaka, Dadirayi; Nhachigule, Carina; Mabunda, Nedio; Loquiha, Osvaldo; Kroidl, Arne und Jani, Ilesh
(2021):
Performance of a True Point-of-Care Assay for HIV-1/2 Viral Load Measurement at Antenatal and Postpartum Services.
In: Jaids-Journal of Acquired Immune Deficiency Syndromes, Bd. 87, Nr. 1: S. 693-699
Sabiiti, Wilber; Azam, Khalide; Farmer, Eoghan Charles William; Kuchaka, Davis; Mtafya, Bariki; Bowness, Ruth; Oravcova, Katarina; Honeyborne, Isobella; Evangelopoulos, Dimitrios; McHugh, Timothy Daniel; Khosa, Celso; Rachow, Andrea; Heinrich, Norbert; Kampira, Elizabeth; Davies, Geraint; Bhatt, Nilesh; Ntinginya, Elias N.; Viegas, Sofia; Jani, Ilesh; Kamdolozi, Mercy; Mdolo, Aaron; Khonga, Margaret; Boeree, Martin J.; Phillips, Patrick P. J.; Sloan, Derek; Hoelscher, Michael; Kibiki, Gibson und Gillespie, Stephen H.
(2020):
Tuberculosis bacillary load, an early marker of disease severity: the utility of tuberculosis Molecular Bacterial Load Assay.
In: Thorax, Bd. 75, Nr. 7: S. 606-608
[PDF, 703kB]
Msafiri, Frank; Joachim, Agricola; Held, Kathrin; Nadai, Yuka; Chissumba, Raquel Matavele; Geldmacher, Christof; Aboud, Said; Stohr, Wolfgang; Viegas, Edna; Kroidl, Arne; Bakari, Muhammad; Munseri, Patricia J.; Wahren, Britta; Sandstrom, Eric; Robb, Merlin L.; McCormack, Sheena; Joseph, Sarah; Jani, Ilesh; Ferrari, Guido; Rao, Mangala; Biberfeld, Gunnel; Lyamuya, Eligius und Nilsson, Charlotta
(2020):
Frequent Anti-V1V2 Responses Induced by HIV-DNA Followed by HIV-MVA with or without CN54rgp140/GLA-AF in Healthy African Volunteers.
In: Microorganisms, Bd. 8, Nr. 11, 1722
Rachow, Andrea; Ivanova, Olena; Wallis, Robert; Charalambous, Salome; Jani, Ilesh; Bhatt, Nilesh; Kampmann, Beate; Sutherland, Jayne; Ntinginya, Nyanda E.; Evans, Denise; Lönnroth, Knut; Niemann, Stefan; Schaible, Ulrich E.; Geldmacher, Christof; Sanne, Ian; Hölscher, Michael und Churchyard, Gavin
(2019):
TB sequel: incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB – a study protocol.
In: BMC Pulmonary Medicine
19:4
[PDF, 755kB]
Chissumba, Raquel Matavele; Luciano, Abilio; Namalango, Eduardo; Bauer, Asli; Bhatt, Nilesh; Wahren, Britta; Nilsson, Charlotta; Geldmacher, Christof; Scarlatti, Gabriella; Jani, Ilesh und Kestens, Luc
(2018):
Regulatory T cell abundance and activation status before and after priming with HIVIS-DNA and boosting with MVA-HIV/rgp140/GLA-AF may impact the magnitude of the vaccine-induced immune responses.
In: Immunobiology, Bd. 223, Nr. 12: S. 792-801
Viegas, Edna O.; Kroidl, Arne; Munseri, Patricia J.; Missanga, Marco; Nilsson, Charlotte; Tembe, Nelson; Bauer, Asli; Joachim, Agricola; Joseph, Sarah; Mann, Philipp; Geldmacher, Christof; Fleck, Sue; Stohr, Wolfgang; Scarlatti, Gabriella; Aboud, Said; Bakari, Muhammad; Maboko, Leonard; Hoelscher, Michael; Wahren, Britta; Robb, Merlin L.; Weber, Jonathan; McCormack, Sheena; Biberfeld, Gunnel; Jani, Ilesh; Sandstrom, Eric und Lyamuya, Eligius
(2018):
Optimizing the immunogenicity of HIV prime-boost DNA-MVA-rgp140/GLA vaccines in a phase II randomized factorial trial design.
In: PLOS One 13(11), e0206838 [PDF, 1MB]
In: PLOS One 13(11), e0206838 [PDF, 1MB]